Dexbrompheniramine and phenylephrine and Larotrectinib Capsules
Determining the interaction of Dexbrompheniramine and phenylephrine and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexbrompheniramine and phenylephrine-Larotrectinib Oral Solution
- Dexbrompheniramine and phenylephrine-Larotrectinib Sulfate
- Dexbrompheniramine and phenylephrine-Lartruvo
- Dexbrompheniramine and phenylephrine-Larynex
- Dexbrompheniramine and phenylephrine-Laryng-O-Jet
- Dexbrompheniramine and phenylephrine-Laryngesic
- Larotrectinib Capsules-Dexbrompheniramine and Phenylephrine Syrup
- Larotrectinib Capsules-Dexbrompheniramine and Phenylephrine Tablets
- Larotrectinib Capsules-Dexbrompheniramine and pseudoephedrine
- Larotrectinib Capsules-Dexbrompheniramine and Pseudoephedrine Solution
- Larotrectinib Capsules-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Larotrectinib Capsules-Dexbrompheniramine and Pseudoephedrine Tablets